Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size is USD 756 Million in 2026

Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market (By Product Type: Viscosupplements, Stem Cell Therapy Injections, Botulinum Toxin Injections, Combination Injections, Other Biologic Injections; By Mechanism of Action: Lubrication, Anti-inflammatory, and Regenerative; By Disease Severity: Mild Knee OA, Moderate Knee OA, and Severe Knee OA; By Age Group: 40–60 Years and Above 60 Years; By Duration/Dosing Frequency: Weekly over 3–5 Weeks, Multiple Dose Regimen, Single-Dose Therapy, and Monthly; By End Use: Orthopedic Clinics, Hospitals, Ambulatory Surgical Centers (ASCs), Sports Medicine Clinics, and Research Institutes / Regenerative Medicine Centers) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 668 | Published : 12 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 7 Mn

Forecast Year,

USD 1511.25 Mn

CAGR, 2026 - 2035

Report Coverage

Asia Pacific

Download Databook

The Asia Pacific knee osteoarthritis (OA) injectable treatments market size was estimated at USD 700 million in 2025 and is projected to be worth around USD 1511.25 million by 2035, growing at a CAGR of 8% from 2026 to 2035. Rising joint-related problems and growing investment in injectable therapies are boosting the market.

Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 700 Million
Market Size in 2026	USD 756 Million
Market Size by 2035	USD 1511.25 Million
CAGR 2026 to 2035	8%
Base Year	2025
Forecast Period	2026 to 2035

The Asia-Pacific nee osteoarthritis (OA) injectable treatments market is experiencing growth, driven by an expanding aging population and a rising incidence of joint-related disorders in major economies within the region. Improved access to diagnostic services and heightened physician awareness support earlier identification and treatment initiation.

Enhancements in healthcare infrastructure and increased public health expenditure are improving the availability of pharmacological and injectable therapies. Additionally, changing lifestyles and a higher prevalence of obesity contribute to the growing demand for long-term management of osteoarthritis. Ongoing investments by pharmaceutical companies in regional product launches and clinical development further support market expansion.

Segments	Shares (%)
Viscosupplements	45%
Stem Cell Therapy Injections	25%
Botulinum Toxin Injections	12%
Combination Injections	10%
Other Biologic Injections	8%

Viscosupplements - viscosupplements provide lubrication and cushioning to relieve joint pain. The viscosupplements segment dominated with 40% share due to significant use and proven effectiveness in treating knee osteoarthritis and a preference for minimally invasive pain management.
Stem Cell Therapy Injections - Injections aimed at regenerating cartilage and reducing inflammation. The stem cell therapy injections held 30% share, as regenerative therapies continue to advance in the OA treatment space, and there is increased investment in stem cell research.

Segments	Shares (%)
Lubrication	55%
Anti-inflammatory	25%
Regenerative	20%

Lubrication - Injections that provide joint lubrication and reduce friction. The lubrication segment dominated with 55% share due to the growing demand for mechanical relief and proven efficacy in treating knee OA symptoms.
Anti-inflammatory - Injections aimed at lowering inflammation and alleviating pain. The anti-inflammatory segment held 25% share, commonly used in managing moderate knee OA.
These injections provide immediate pain relief for the region's rapidly growing, aging population.

Segments	Shares (%)
Moderate Knee OA	40%
Severe Knee OA	45%
Mild Knee OA	20%

Moderate knee OA - Treatment for intermediate-stage knee OA with moderate symptoms. The moderate knee OA segment held 35% share due to the growing incidence of moderate OA requiring intervention to manage pain.
Severe knee OA - Treatment for advanced knee OA with significant pain and limited mobility. The severe knee OA segment held 45% share, driven by the high burden of disease in China, Japan, and India.

Segments	Shares (%)
40–60 Years	50%
> 60 years	40%

40-60 years - Treatment for middle-aged individuals who experience moderate knee OA symptoms. The 40-60 years segment dominated with 50% share due to the rising incidence of OA in this age group and growing awareness of treatment options.
>60 years - Treatment for elderly patients with advanced knee OA. The >60 years segment held 40% share, driven by the increasing elderly population and higher OA prevalence in this group. Patients over 60 often prefer minimally invasive procedures.

Segments	Shares (%)
Weekly over 3–5 weeks	25%
Multiple dose regimen	40%
Single-Dose Therapy	20%
Monthly	15%

Multiple-dose regimen - Treatment that includes injections over time for ongoing symptom management. The multiple dose regimen segment dominated with 40% share due to its sustained effectiveness in managing knee OA symptoms over time.
Weekly over 3-5 weeks - A regimen including weekly injections over a set period. The weekly segment over 3- 5 weeks held 25% share, popular for its higher frequency of dosing in moderate OA treatment and offers comparable pain relief.

Segments	Shares (%)
Orthopedic clinics	25%
Hospitals	45%
Ambulatory Surgical Centers (ASCs)	15%
Sports Medicine Clinics	7%
Research Institutes / Regenerative Medicine Centers	8%

Hospitals - hospitals are medical centers providing comprehensive OA treatments and advanced care. The hospitals segment dominated with 45% share due to their capacity for advanced treatment options and high patient volumes.
Orthopedic clinics - orthopedic clinics are specialised clinics emphasizing on musculoskeletal issues, including knee OA. The orthopedic clinics segment held 25% share, with a significant role in outpatient care and specialized knee treatments.

Top Companies in the Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market

Alcon, Inc.
Allergan plc
Anika Therapeutics, Inc.
Arthrex, Inc.
Bioventus, Inc.
Ferring Pharmaceuticals Inc.
Fidia Farmaceutici S.p.A.
Flexion Therapeutics, Inc.
Galderma S.A.
Hyaltech Ltd.
Landec Corporation (LifeCore Biomedical, Inc.)
Meiji Seika Pharma Ltd.
Merz Pharmaceuticals GmbH (Merz Aesthetics, Inc.)
OrthogenRx, Inc.
Roche Holding AG (F. Hoffmann-La Roche AG)
Royal Biologics
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Zimmer Biomet

Segments Covered in the Report

By Product Type

Viscosupplements
Stem Cell Therapy Injections
Botulinum Toxin Injections
Combination Injections
Other Biologic Injections

By Mechanism of Action

Lubrication
Anti-inflammatory
Regenerative

By Disease Severity

Moderate Knee OA
Severe Knee OA
Mild Knee OA

By Age Group

40–60 Years
60 years

By Duration/Dosing Frequency

Weekly over 3–5 weeks
Multiple dose regimen
Single-Dose Therapy
Monthly

By End Use

Orthopedic clinics
Hospitals
Ambulatory Surgical Centers (ASCs)
Sports Medicine Clinics
Research Institutes / Regenerative Medicine Centers

List of Tables & Figures

List of Tables

Table 1: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Product Type, 2025-2035 (USD Million)
Table 2: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Mechanism of Action, 2025-2035 (USD Million)
Table 3: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Disease Severity, 2025-2035 (USD Million)
Table 4: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Age Group, 2025-2035 (USD Million)
Table 5: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Duration/Dosing Frequency, 2025-2035 (USD Million)
Table 6: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by End Use, 2025-2035 (USD Million)
Table 7: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Viscosupplements, 2025-2035 (USD Million)
Table 8: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Stem Cell Therapy Injections, 2025-2035 (USD Million)
Table 9: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Botulinum Toxin Injections, 2025-2035 (USD Million)
Table 10: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Combination Injections, 2025-2035 (USD Million)
Table 11: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Other Biologic Injections, 2025-2035 (USD Million)
Table 12: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Lubrication, 2025-2035 (USD Million)
Table 13: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Anti-inflammatory, 2025-2035 (USD Million)
Table 14: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Regenerative, 2025-2035 (USD Million)
Table 15: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Moderate Knee OA, 2025-2035 (USD Million)
Table 16: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Severe Knee OA, 2025-2035 (USD Million)
Table 17: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Mild Knee OA, 2025-2035 (USD Million)
Table 18: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by 40-60 Years, 2025-2035 (USD Million)
Table 19: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by 60 Years, 2025-2035 (USD Million)
Table 20: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Weekly over 3-5 weeks, 2025-2035 (USD Million)
Table 21: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Multiple Dose Regimen, 2025-2035 (USD Million)
Table 22: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Single-Dose Therapy, 2025-2035 (USD Million)
Table 23: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Monthly, 2025-2035 (USD Million)
Table 24: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Orthopedic Clinics, 2025-2035 (USD Million)
Table 25: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Hospitals, 2025-2035 (USD Million)
Table 26: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Ambulatory Surgical Centers (ASCs), 2025-2035 (USD Million)
Table 27: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Sports Medicine Clinics, 2025-2035 (USD Million)
Table 28: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Size, by Research Institutes / Regenerative Medicine Centers, 2025-2035 (USD Million)

List of Figures

Figure 1: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by Product Type, 2025 (%)
Figure 2: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by Mechanism of Action, 2025 (%)
Figure 3: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by Disease Severity, 2025 (%)
Figure 4: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by Age Group, 2025 (%)
Figure 5: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by Duration/Dosing Frequency, 2025 (%)
Figure 6: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Share, by End Use, 2025 (%)
Figure 7: Asia Pacific Knee Osteoarthritis (OA) Injectable Treatments Market Forecast, 2025-2035 (USD Million)
Figure 8: Viscosupplements Segment Market Forecast, 2025-2035 (USD Million)
Figure 9: Stem Cell Therapy Injections Segment Market Forecast, 2025-2035 (USD Million)
Figure 10: Botulinum Toxin Injections Segment Market Forecast, 2025-2035 (USD Million)
Figure 11: Combination Injections Segment Market Forecast, 2025-2035 (USD Million)
Figure 12: Other Biologic Injections Segment Market Forecast, 2025-2035 (USD Million)
Figure 13: Lubrication Segment Market Forecast, 2025-2035 (USD Million)
Figure 14: Anti-inflammatory Segment Market Forecast, 2025-2035 (USD Million)
Figure 15: Regenerative Segment Market Forecast, 2025-2035 (USD Million)
Figure 16: Moderate Knee OA Segment Market Forecast, 2025-2035 (USD Million)
Figure 17: Severe Knee OA Segment Market Forecast, 2025-2035 (USD Million)
Figure 18: Mild Knee OA Segment Market Forecast, 2025-2035 (USD Million)
Figure 19: 40-60 Years Segment Market Forecast, 2025-2035 (USD Million)
Figure 20: 60 Years Segment Market Forecast, 2025-2035 (USD Million)
Figure 21: Weekly over 3-5 weeks Segment Market Forecast, 2025-2035 (USD Million)
Figure 22: Multiple Dose Regimen Segment Market Forecast, 2025-2035 (USD Million)
Figure 23: Single-Dose Therapy Segment Market Forecast, 2025-2035 (USD Million)
Figure 24: Monthly Segment Market Forecast, 2025-2035 (USD Million)
Figure 25: Orthopedic Clinics Segment Market Forecast, 2025-2035 (USD Million)
Figure 26: Hospitals Segment Market Forecast, 2025-2035 (USD Million)
Figure 27: Ambulatory Surgical Centers (ASCs) Segment Market Forecast, 2025-2035 (USD Million)
Figure 28: Sports Medicine Clinics Segment Market Forecast, 2025-2035 (USD Million)
Figure 29: Research Institutes / Regenerative Medicine Centers Segment Market Forecast, 2025-2035 (USD Million)

Research Methodology

Related Databooks

March 2026